Attorney

New Ovarian Cancer Immunotherapy Study Poses Question: Can Microbiome Influence Treatment Response?





A clinical study with Keytruda (pembrolizumab) in a novel untried combination is the first ovarian cancer clinical trial to incorporate gut flora analysis.  Dr. Emese Zsiros, the study’s Principal Investigator, explains a new, unique clinical trial investigating immunotherapy for patients with advanced ovarian cancer. A new clinical study underway at Roswell Park Cancer Institute is […]
The post New Ovarian Cancer Immunotherapy Study Poses Question: Can Microbiome Influence Treatment Response? appeared first on CancerConnect News.

To Top